CVRX INC (CVRX)
US1266381052 - Common Stock
Overall CVRX gets a fundamental rating of 3 out of 10. We evaluated CVRX against 187 industry peers in the Health Care Equipment & Supplies industry. CVRX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CVRX is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CVRX has reported negative net income.
In the past year CVRX has reported a negative cash flow from operations.
In the past 5 years CVRX always reported negative net income.
CVRX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
CVRX has a Return On Assets of -48.99%. This is in the lower half of the industry: CVRX underperforms 68.45% of its industry peers.
CVRX has a Return On Equity of -78.49%. This is in the lower half of the industry: CVRX underperforms 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -48.99% | ||
| ROE | -78.49% | ||
| ROIC | N/A |
ROA(3y)-32.39%
ROA(5y)-33.93%
ROE(3y)-40.56%
ROE(5y)-357.7%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of CVRX (84.45%) is better than 94.65% of its industry peers.
CVRX's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CVRX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 84.45% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.34%
GM growth 5YN/A
2. Health
2.1 Basic Checks
CVRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CVRX has been increased compared to 1 year ago.
The debt/assets ratio for CVRX is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -2.98, we must say that CVRX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.98, CVRX is doing worse than 65.78% of the companies in the same industry.
A Debt/Equity ratio of 0.44 indicates that CVRX is not too dependend on debt financing.
CVRX has a worse Debt to Equity ratio (0.44) than 60.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.98 |
ROIC/WACCN/A
WACC9.56%
2.3 Liquidity
CVRX has a Current Ratio of 12.18. This indicates that CVRX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 12.18, CVRX belongs to the best of the industry, outperforming 96.79% of the companies in the same industry.
A Quick Ratio of 10.87 indicates that CVRX has no problem at all paying its short term obligations.
CVRX has a Quick ratio of 10.87. This is amongst the best in the industry. CVRX outperforms 95.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 12.18 | ||
| Quick Ratio | 10.87 |
3. Growth
3.1 Past
CVRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.75%.
The Revenue has grown by 59.53% in the past year. This is a very strong growth!
Measured over the past years, CVRX shows a very strong growth in Revenue. The Revenue has been growing by 86.58% on average per year.
EPS 1Y (TTM)-18.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.09%
Revenue 1Y (TTM)59.53%
Revenue growth 3Y86.58%
Revenue growth 5YN/A
Sales Q2Q%34.98%
3.2 Future
The Earnings Per Share is expected to grow by 9.61% on average over the next years. This is quite good.
CVRX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.16% yearly.
EPS Next Y-28.71%
EPS Next 2Y0.07%
EPS Next 3Y7.1%
EPS Next 5Y9.61%
Revenue Next Year29.8%
Revenue Next 2Y31.53%
Revenue Next 3Y32.86%
Revenue Next 5Y32.16%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
CVRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CVRX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.07%
EPS Next 3Y7.1%
5. Dividend
5.1 Amount
CVRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CVRX INC
NASDAQ:CVRX (7/2/2024, 3:01:50 PM)
After market: 11.78 0 (0%)11.78
+0.07 (+0.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap254.45M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -48.99% | ||
| ROE | -78.49% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 84.45% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 12.18 | ||
| Quick Ratio | 10.87 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-18.75%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-28.71%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)59.53%
Revenue growth 3Y86.58%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y